Thomas Laage



  • Thomas Laage

    2011 - MPH, Harvard School of Public Health

    1976 - MD, Albert Einstein College of Medicine

    1973 - AB (Biochemical Sciences), Harvard University


    Dr Laage has published articles on urinary tract infection, treatment-resistant anxiety and depression, bioactive glass in periodontal defects, and Data Safety and Monitoring Boards in adaptive clinical trials. He has expertise in Cardiovascular and Gastrointestinal Phase III device trials and regulatory, medical writing, and clinical trial involvement in Analgesia, Pediatrics, Rare diseases and CNS disorders. He practiced psychiatry for many years, teaching residents and medical students at the McLean Hospital and Harvard Medical School. Dr Laage has consulted to medical communications companies and clinical trials and has performed executive coaching. Since 2012, he has been the Director of Regulatory Medical Writing at Premier Research Group Ltd. Dr Laage joined Edanz Group as a research consultant and writer in 2010.